The ALNY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALNY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ALNY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ALNY Detailed Price Forecast - CNN Money||View ALNY Detailed Summary - Google Finance|
|View ALNY Detailed Summary - Yahoo! Finance||View ALNY Stock Research & Analysis - Zacks.com|
|View ALNY Trends & Analysis - Trade-Ideas||View ALNY Major Holders - Barrons|
|View ALNY Call Transcripts - NASDAQ||View ALNY Breaking News & Analysis - Seeking Alpha|
|View ALNY Annual Report - CompanySpotlight.com||View ALNY OTC Short Report - OTCShortReport.com|
|View ALNY Fundamentals - TradeKing||View ALNY SEC Filings - Bar Chart|
|View Historical Prices for ALNY - The WSJ||View Performance/Total Return for ALNY - Morningstar|
|View the Analyst Estimates for ALNY - MarketWatch||View the Earnings History for ALNY - CNBC|
|View the ALNY Earnings - StockMarketWatch||View ALNY Buy or Sell Recommendations - MacroAxis|
|View the ALNY Bullish Patterns - American Bulls||View ALNY Short Pain Metrics - ShortPainBot.com|
|View ALNY Stock Mentions - StockTwits||View ALNY Stock Mentions - PennyStockTweets|
|View ALNY Stock Mentions - Twitter||View ALNY Investment Forum News - Investor Hub|
|View ALNY Stock Mentions - Yahoo! Message Board||View ALNY Stock Mentions - Seeking Alpha|
|View Insider Transactions for ALNY - SECform4.com||View Insider Transactions for ALNY - Insider Cow|
|View ALNY Major Holdings Summary - CNBC||View Insider Disclosure for ALNY - OTC Markets|
|View Insider Transactions for ALNY - Yahoo! Finance||View Institutional Holdings for ALNY - NASDAQ|
|View ALNY Stock Insight & Charts - FinViz.com||View ALNY Investment Charts - StockCharts.com|
|View ALNY Stock Overview & Charts - BarChart||View ALNY User Generated Charts - Trading View|
ALNYLAM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alnylam Pharmaceuticals, Inc. To Contact The Firm
Posted on Thursday September 20, 2018
NEW YORK , Sept. 20, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities claims against Alnylam Pharmaceuticals, Inc. ("Alnylam" ...
See what the IHS Markit Score report has to say about Alnylam Pharmaceuticals Inc.
Posted on Thursday September 20, 2018
Alnylam Pharmaceuticals Inc NASDAQ/NGS:ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
Posted on Tuesday September 18, 2018
NEW YORK, NY / ACCESSWIRE / September 18, 2018 / Pomerantz LLP is investigating claims on behalf of investors of Alnylam Pharmaceuticals, Inc. ("Alnylam" or the "Company") (ALNY). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 9980. The investigation concerns whether Alnylam and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
What Solid Biosciences’ Valuation Trend Indicates
Posted on Friday September 14, 2018
Solid Biosciences (SLDB) incurred a net loss of $17.98 million in the second quarter of 2018, which compares to a net loss of $11.31 million in the second quarter of 2017, translating to a net loss per share of $0.52 in the second quarter of 2018. Its net loss per share was $0.66 in the second quarter of 2017. The decrease in net loss per share was due to an increase in the company’s outstanding shares, which increased from 17.04 million in the second quarter of 2017 to 34.45 million in the second quarter of 2018.